High concentration Anti-c5 formulations

MYPI2025002172A0Undetermined Publication Date: 2021-02-16REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002172
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-08-14
Filing Date
2020-08-14
Publication Date
2021-02-16
Patent Text Reader

Abstract

The present disclosure includes high concentration, low viscosity pharmaceutical formulations that include an anti-C5 antibody or antigen-binding fragment thereof and arginine. Such formulations may be provided in association with an RNAi molecule such as cemdisiran. Methods of treating C5-associated diseases such as PNH and aHUS are also provided.
Need to check novelty before this filing date? Find Prior Art